Stone X Group Inc. Spruce Biosciences, Inc. Transaction History

Stone X Group Inc.

  • $2.29 Trillion
  • Q3 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Aug 13, 2025
BUY
$1.18 - $2.19 $11,856 - $22,005
10,048 New
10,048 $13.8 Million
Q2 2022

Aug 13, 2025
BUY
$1.28 - $2.23 $15,232 - $26,537
11,900 New
11,900 $20.7 Million

Others Institutions Holding SPRB

# of Institutions
3
Shares Held
4.85M
Call Options Held
0
Put Options Held
0
View Full List

About SPRUCE BIOSCIENCES, INC.

SPRB Quotes by TradingView
  • Ticker SPRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,560,200
  • Market Cap $2.51B
  • Description
  • Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...
More about SPRB
Track This Portfolio

Track Stone X Group Inc. Portfolio

Follow Stone X Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email